Lecap Asset Management Ltd. bought a new position in shares of Accenture PLC (NYSE:ACN – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 6,127 shares of the information technology services provider’s stock, valued at approximately $1,511,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Global Retirement Partners LLC acquired a new position in shares of Accenture in the 2nd quarter worth approximately $2,658,000. C WorldWide Group Holding A S raised its stake in Accenture by 35.9% during the second quarter. C WorldWide Group Holding A S now owns 8,148 shares of the information technology services provider’s stock worth $2,435,000 after buying an additional 2,151 shares during the last quarter. Truist Financial Corp boosted its position in Accenture by 7.0% during the second quarter. Truist Financial Corp now owns 436,202 shares of the information technology services provider’s stock valued at $130,376,000 after acquiring an additional 28,685 shares during the last quarter. Norges Bank acquired a new stake in Accenture during the 2nd quarter worth about $2,216,850,000. Finally, Prudential PLC raised its position in shares of Accenture by 20.4% in the 2nd quarter. Prudential PLC now owns 56,130 shares of the information technology services provider’s stock worth $16,777,000 after acquiring an additional 9,510 shares in the last quarter. Institutional investors and hedge funds own 75.14% of the company’s stock.
Insider Buying and Selling at Accenture
In related news, insider Manish Sharma sold 6,902 shares of the firm’s stock in a transaction dated Wednesday, October 22nd. The shares were sold at an average price of $250.01, for a total transaction of $1,725,569.02. Following the completion of the sale, the insider owned 1,860 shares in the company, valued at approximately $465,018.60. This trade represents a 78.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Mauro Macchi sold 500 shares of the stock in a transaction that occurred on Wednesday, January 7th. The shares were sold at an average price of $280.00, for a total transaction of $140,000.00. Following the transaction, the chief executive officer directly owned 7,623 shares of the company’s stock, valued at $2,134,440. This represents a 6.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 35,151 shares of company stock worth $8,841,525. 0.02% of the stock is currently owned by insiders.
Accenture Stock Down 0.7%
Accenture (NYSE:ACN – Get Free Report) last released its quarterly earnings results on Thursday, December 18th. The information technology services provider reported $3.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.73 by $0.21. The business had revenue of $18.74 billion during the quarter, compared to the consensus estimate of $18.51 billion. Accenture had a return on equity of 26.65% and a net margin of 10.76%.The company’s quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.59 EPS. Accenture has set its FY 2026 guidance at 13.520-13.900 EPS. On average, equities research analysts forecast that Accenture PLC will post 12.73 EPS for the current fiscal year.
Accenture Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Tuesday, January 13th will be issued a dividend of $1.63 per share. The ex-dividend date is Tuesday, January 13th. This represents a $6.52 annualized dividend and a yield of 2.4%. Accenture’s dividend payout ratio is 53.88%.
Trending Headlines about Accenture
Here are the key news stories impacting Accenture this week:
- Positive Sentiment: Truist began coverage on ACN with a “buy” and $317 price target, giving the stock visible analyst backing and implying meaningful upside. Accenture (ACN) Has a New Rating from Truist Financial
- Positive Sentiment: Accenture agreed to acquire Faculty, an AI-native services/products firm — a deal that expands its GenAI capabilities and go?to?market for client AI transformations. This is a strategic revenue-growth catalyst. Accenture to Acquire Faculty to Scale AI Capabilities
- Positive Sentiment: Partnership with NTT DOCOMO GLOBAL to build Universal Wallet Infrastructure showcases Accenture’s positioning in large data-led, identity and digital?trust initiatives — another strategic growth opportunity. NTT DOCOMO GLOBAL and Accenture Launch Universal Wallet Infrastructure
- Neutral Sentiment: Coverage and valuation pieces are taking stock of the AI M&A and partnerships — useful context for investors but not an immediate catalyst on their own. Assessing Accenture (ACN) Valuation After New AI Acquisition And Digital Trust Partnership
- Neutral Sentiment: Rothschild & Co Redburn adjusted its price target (low relative to the stock) and maintained neutral — a reminder that some analysts remain cautious about near?term upside. Rothschild & Co Redburn adjusts PT
- Negative Sentiment: Coverage flagged softer public?sector demand, which could pressure consulting revenue in the near term and weigh on sentiment for a material part of Accenture’s business. Is Softer Public-Sector Demand Undermining the Resilience of Accenture’s Consulting Engine?
- Negative Sentiment: Insider selling: CEO Mauro Macchi sold 500 shares and General Counsel Joel Unruch sold 1,332 shares in early January. Sizeable insiders remain invested, but these disclosed sales can create short?term negative optics. SEC Filing – CEO Sale SEC Filing – GC Sale
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on ACN shares. Truist Financial assumed coverage on Accenture in a research note on Tuesday. They set a “buy” rating and a $317.00 target price for the company. Susquehanna raised their price objective on shares of Accenture from $270.00 to $277.00 and gave the stock a “neutral” rating in a research report on Friday, December 19th. Stifel Nicolaus dropped their target price on shares of Accenture from $355.00 to $315.00 and set a “buy” rating on the stock in a research report on Tuesday, September 16th. BNP Paribas Exane reduced their price target on shares of Accenture from $300.00 to $255.00 and set a “neutral” rating for the company in a report on Wednesday, September 24th. Finally, Rothschild & Co Redburn increased their price objective on shares of Accenture from $205.00 to $210.00 and gave the stock a “neutral” rating in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $295.84.
Get Our Latest Stock Analysis on ACN
About Accenture
Accenture is a global professional services company that provides a broad range of services and solutions in strategy, consulting, digital, technology and operations. The firm works with organizations across industries to design and implement business transformation programs, deploy and manage enterprise technology, optimize operations, and develop customer and digital experiences. Its offerings encompass management and technology consulting, systems integration, application and infrastructure services, cloud migration and managed services, as well as security and analytics capabilities.
The company delivers industry- and function-specific solutions, combining consulting expertise with proprietary tools, platforms and partnerships with major technology vendors.
See Also
- Five stocks we like better than Accenture
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- YDES Could Be 2026’s Biotech Breakthrough
- ALERT: Drop these 5 stocks before January 2026!
Receive News & Ratings for Accenture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture and related companies with MarketBeat.com's FREE daily email newsletter.
